STAAR Surgical Company (STAA)

STAAR Surgical Company Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	183.04	86.48	199.71	152.45	119.97
Short-Term Investments	37.69	125.16	0	0	0
Cash & Cash Equivalents	220.73	211.64	199.71	152.45	119.97
Cash Growth	4.29%	5.98%	31.00%	27.08%	15.49%
Receivables	94.7	62.45	43.53	35.23	31
Inventory	35.13	24.16	17.27	18.11	17.14
Other Current Assets	14.71	13.48	10.9	10.63	6.56
Total Current Assets	365.27	311.72	271.41	216.42	174.67
Property, Plant & Equipment	101.41	81.53	67.73	33.39	25.62
Long-Term Investments	11.7	13.9	0	0	0
Goodwill and Intangibles	1.79	1.96	2	2.06	2.08
Other Long-Term Assets	8.53	9.7	4.64	5.55	5.16
Total Long-Term Assets	123.42	107.1	74.37	41	32.86
Total Assets	488.69	418.82	345.78	257.42	207.52
Accounts Payable	13.56	11.58	8.7	7.47	8.05
Current Debt	4.37	3.69	3.41	4.22	5.09
Other Current Liabilities	47.11	36.45	36.69	29.54	21.34
Total Current Liabilities	65.04	51.72	48.8	41.24	34.48
Long-Term Debt	31.47	27.35	28.65	6.58	4.45
Other Long-Term Liabilities	6.24	3.64	9.77	12.38	8.71
Total Long-Term Liabilities	37.7	30.99	38.42	18.96	13.16
Total Liabilities	102.74	82.71	87.22	60.19	47.64
Total Debt	35.83	31.04	32.06	10.8	9.54
Debt Growth	15.45%	-3.19%	196.89%	13.21%	78.73%
Retained Earnings	-47.37	-68.72	-111.39	-135.89	-141.8
Comprehensive Income	-4.11	0.16	-4.05	-5.55	-3.05
Shareholders' Equity	385.95	336.11	258.56	197.22	159.88
Net Cash / Debt	184.89	180.6	167.65	141.65	110.43
Net Cash / Debt Growth	2.38%	7.73%	18.35%	28.28%	12.07%
Net Cash Per Share	3.74	3.66	3.39	2.95	2.35
Working Capital	300.23	260.01	222.61	175.18	140.19
Book Value Per Share	7.95	7.00	5.48	4.33	3.59

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).